These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 36483446)

  • 21. Decreased Antibody Response After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Patients With Down Syndrome.
    Streng BMM; Bont M; Delemarre EM; Binnendijk RS; Smit G; den Hartog G; Coppus AMW; de Vries E; Weijerman ME; Lamberts R; de Graaf G; van der Klis FR; Vidarsson G; Rave N; Bont LJ; Wildenbeest JG
    J Infect Dis; 2022 Sep; 226(4):673-677. PubMed ID: 35748853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current therapeutic options for coronavirus disease 2019 (COVID-19)-lessons learned from severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS) therapy: a systematic review protocol.
    Zhang ZL; Zhong H; Liu YX; Le KJ; Cui M; Yu YT; Gu ZC; Gao Y; Lin HW
    Ann Transl Med; 2020 Nov; 8(22):1527. PubMed ID: 33313272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of acute severe acute respiratory syndrome coronavirus 2 infection on male hormone profile,
    Huang Z; Do DV; Beh D; Lee CK; Yan B; Foo R; Tambyah PA
    F S Sci; 2022 Feb; 3(1):29-34. PubMed ID: 34841282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV).
    Noor R
    Arch Microbiol; 2021 Jul; 203(5):1943-1951. PubMed ID: 33682075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies against SARS-CoV-2 Suggestive of Single Events of Spillover to Cattle, Germany.
    Wernike K; Böttcher J; Amelung S; Albrecht K; Gärtner T; Donat K; Beer M
    Emerg Infect Dis; 2022 Sep; 28(9):1916-1918. PubMed ID: 35914515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
    Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
    Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium.
    Milewska A; Kula-Pacurar A; Wadas J; Suder A; Szczepanski A; Dabrowska A; Owczarek K; Marcello A; Ochman M; Stacel T; Rajfur Z; Sanak M; Labaj P; Branicki W; Pyrc K
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32434888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coinfection with severe acute respiratory syndrome coronavirus-2 and other respiratory viruses at a tertiary hospital in Korea.
    Kim Z; Lee JH
    J Clin Lab Anal; 2021 Aug; 35(8):e23868. PubMed ID: 34273182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First Reported Nosocomial Outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 in a Pediatric Dialysis Unit.
    Schwierzeck V; König JC; Kühn J; Mellmann A; Correa-Martínez CL; Omran H; Konrad M; Kaiser T; Kampmeier S
    Clin Infect Dis; 2021 Jan; 72(2):265-270. PubMed ID: 33501962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody Response to SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease: Results of a Single-Center Cohort Study in a Tertiary Hospital in Germany.
    Classen JM; Muzalyova A; Nagl S; Fleischmann C; Ebigbo A; Römmele C; Messmann H; Schnoy E
    Dig Dis; 2022; 40(6):719-727. PubMed ID: 34915480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe acute respiratory syndrome coronavirus 2 antibody prevalence in adult patients with short bowel syndrome-A German multicenter cross-sectional study.
    Blüthner E; Pape UF; Blumenstein I; Wichmann J; Tacke F; Moosburner S
    JPEN J Parenter Enteral Nutr; 2022 Aug; 46(6):1404-1411. PubMed ID: 35616296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Impact and Consequences of SARS-CoV-2 Pandemic on a Single University Dermatology Outpatient Clinic in Germany.
    Wang R; Helf C; Tizek L; Neuhauser R; Eyerich K; Zink A; Eberlein B; Biedermann T; Brockow K; Boehner A
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32858870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. mRNA-Based Vaccine BNT162b2 Might Reduce Severe Acute Respiratory Syndrome Coronavirus 2 B.1.1.7 Variant Transmission in Japanese Population.
    Matsunaga T; Higashidate Y; Inazawa N; Ando S; Takahashi M
    Cureus; 2021 Oct; 13(10):e19140. PubMed ID: 34737915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe Acute Respiratory Syndrome Coronavirus ORF7a Inhibits Bone Marrow Stromal Antigen 2 Virion Tethering through a Novel Mechanism of Glycosylation Interference.
    Taylor JK; Coleman CM; Postel S; Sisk JM; Bernbaum JG; Venkataraman T; Sundberg EJ; Frieman MB
    J Virol; 2015 Dec; 89(23):11820-33. PubMed ID: 26378163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Humoral Immune Responses in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Henss L; Scholz T; von Rhein C; Wieters I; Borgans F; Eberhardt FJ; Zacharowski K; Ciesek S; Rohde G; Vehreschild M; Stephan C; Wolf T; Hofmann-Winkler H; Scheiblauer H; Schnierle BS
    J Infect Dis; 2021 Jan; 223(1):56-61. PubMed ID: 33128369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi.
    Aggarwal A; Shrivastava A; Kumar A; Ali A
    J Assoc Physicians India; 2020 Jul; 68(7):19-26. PubMed ID: 32602676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2-related outcomes after surgical procedures on SARS-CoV-2-positive patients in a large, urban, safety net medical center.
    Sargent RE; Sener SF; Amaya R; Vazquez E; Bowdish ME; Spellberg B
    Surg Open Sci; 2021 Jul; 5():10-13. PubMed ID: 33969284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the potential impact of targeted vaccination strategies against severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks in the healthcare setting.
    Abdirizak F; Lewis R; Chowell G
    Theor Biol Med Model; 2019 Oct; 16(1):16. PubMed ID: 31587665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.